Coherus Oncology, Inc.
CHRS
$1.60
$0.020.95%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -37.64M | -35.53M | -- | -56.57M | -50.70M |
| Total Depreciation and Amortization | 896.00K | 966.00K | -- | 1.05M | 1.03M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 691.00K | -2.39M | -- | 18.84M | 23.73M |
| Change in Net Operating Assets | 16.34M | -9.39M | -- | 10.86M | 54.54M |
| Cash from Operations | -19.72M | -46.34M | -- | -25.83M | 28.61M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.84M | -67.23M | -- | -17.49M | -542.00K |
| Cash from Investing | -2.84M | -67.23M | -- | -17.49M | -542.00K |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | 0.00 | 0.00 | -- | -- | 0.00 |
| Issuance of Common Stock | 8.06M | 0.00 | -- | -- | 241.00K |
| Repurchase of Common Stock | 0.00 | -3.00K | -- | -264.00K | -10.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 22.00K | 5.00K | -- | -- | 0.00 |
| Cash from Financing | 8.08M | 2.00K | -- | -264.00K | 231.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.47M | -113.56M | -- | -43.58M | 28.30M |